8月21日，英矽智能盘中下跌5.07%，报41.96港元/股，成交额1.61亿港元。前一交易日该股因板块回暖及与元码智药达成mRNA肿瘤疫苗研发合作等多重利好共振大涨逾12%，短期获利盘兑现压力释放。此外，摩根大通于8月20日披露权益变动，在增持好仓至5.06%的同时将淡仓比例由2.17%升至2.23%，多空同步加仓信号令市场情绪趋于谨慎。板块层面，生命科学工具和服务行业今日整体走弱，晶泰控股跌5.03%、药明生物跌1.73%、药明合联跌1.28%，行业共振亦形成压力。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.